12:00 AM
 | 
Aug 18, 2014
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Tirosint levothyroxine: Postmarketing study started

Akrimax Pharmaceuticals LLC (Cranford, N.J.) began the open-label, U.S. postmarketing CONTROL trial to evaluate once-daily Tirosint in hypothyroid patients who have not...

Read the full 97 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >